Notch in the intestine: Regulation of homeostasis and pathogenesis

Annual Review of Physiology

Volumn 75, Issue , 2013, Pages 263-288

  Noah, Taeko K ^a   Shroyer, Noah F ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

secretase; ATOH1; Cell fate determination; Colorectal cancer; Stem cells

Indexed keywords

ADAM PROTEIN; ADAM10 ENDOPEPTIDASE; ATOH1 PROTEIN; BETA CATENIN; CIS ACTING ELEMENT; DLL1 PROTEIN; DLL3 PROTEIN; DLL4 PROTEIN; DNA; EPIDERMAL GROWTH FACTOR; GAMMA SECRETASE; GAMMA SECRETASE INHIBITOR; JAGGED1; JAGGED2; KI 67 ANTIGEN; KRUPPEL LIKE FACTOR 4; MEMBRANE PROTEIN; NEUROGENIC DIFFERENTIATION FACTOR; NEUROGENIN 3; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; PDZ PROTEIN; PROTEIN PATCHED 1; TRANS ACTING FACTOR; TRANSCRIPTION FACTOR HES 1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN RECEPTOR; WNT PROTEIN;

ANATOMICAL VARIATION; CANCER PATIENT; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL FATE; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; COLORECTAL CANCER; CROHN DISEASE; DROSOPHILA; ENDOCYTOSIS; ENTERITIS; GENE EXPRESSION; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; INTESTINE; INTESTINE ABSORPTION; INTESTINE CELL; INTESTINE MUCOSA; MESENCHYME CELL; NERVE CELL; NONHUMAN; NUTRIENT CONTENT; ORGANOGENESIS; PATHOGENESIS; PDZ DOMAIN; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUIESCENT INTESTINAL STEM CELL; REVIEW; SECRETORY CELL; SIGNAL TRANSDUCTION; SMALL INTESTINE; STEM CELL; TUMOR SUPPRESSOR GENE; UBIQUITINATION; ULCERATIVE COLITIS;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; HOMEOSTASIS; HUMANS; INTESTINES; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

EID: 84873637033     PISSN: 00664278     EISSN: 15451585     Source Type: Book Series    
DOI: 10.1146/annurev-physiol-030212-183741     Document Type: Review

References (148)

1. Shroyer NF, Kocoshis SA. 2011. Anatomy and physiology of the small and large intestines. In Pediatric Gastrointestinal and Liver Disease, ed. R Wyllie, J Hyams, M Kay, pp. 324-36. Philadelphia: Elsevier
2. Cheng H, Leblond CP. 1974. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian theory of the origin of the four epithelial cell types. Am. J. Anat. 141:537-61
3. van der Flier LG, van Gijn ME, Hatzis P, Kujala P, Haegebarth A, et al. 2009. Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell 136:903-12
4. Zhu L, Gibson P, Currle DS, Tong Y, Richardson RJ, et al. 2009. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 457:603-7
5. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, et al. 2007. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449:1003-7
6. van der Flier LG, Haegebarth A, Stange DE, van de Wetering M, Clevers H. 2009. OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. Gastroenterology 137:15-17
7. Besson V, Smeriglio P, Wegener A, Relaix F, Nait Oumesmar B, et al. 2011. PW1 gene/paternally expressed gene 3 (PW1/Peg3) identifies multiple adult stem and progenitor cell populations. Proc. Natl. Acad. Sci. USA 108:11470-75
8. Yeung TM, Chia LA, Kosinski CM, Kuo CJ. 2011. Regulation of self-renewal and differentiation by the intestinal stem cell niche. Cell. Mol. Life Sci. 68:2513-23
9. Sangiorgi E, Capecchi MR. 2008. Bmi1 is expressed in vivo in intestinal stem cells. Nat. Genet. 40:915-20
10. Takeda N, Jain R, LeBoeuf MR, Wang Q, Lu MM, Epstein JA. 2011. Interconversion between intestinal stem cell populations in distinct niches. Science 334:1420-24
11. Montgomery RK, Carlone DL, Richmond CA, Farilla L, Kranendonk ME, et al. 2011. Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells. Proc. Natl. Acad. Sci. USA 108:179-84
12. Giannakis M, Stappenbeck TS, Mills JC, Leip DG, Lovett M, et al. 2006. Molecular properties of adult mouse gastric and intestinal epithelial progenitors in their niches. J. Biol. Chem. 281:11292-300
13. Powell AE, Wang Y, Li Y, Poulin EJ, Means AL, et al. 2012. The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Cell 149:146-58
14. Potten CS, Booth C, Tudor GL, Booth D, Brady G, et al. 2003. Identification of a putative intestinal stem cell and early lineage marker; musashi-1. Differentiation 71:28-41
15. Potten CS, Booth C, Pritchard DM. 1997. The intestinal epithelial stem cell: the mucosal governor. Int. J. Exp. Pathol. 78:219-43
16. Roth S, Fodde R. 2011. Quiescent stem cells in intestinal homeostasis and cancer. Cell Commun. Adhes. 18:33-44
17. Yan KS, Chia LA, Li X, Ootani A, Su J, et al. 2012. The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations. Proc. Natl. Acad. Sci. USA 109:466-71
18. Barolo S, Posakony JW. 2002. Three habits of highly effective signaling pathways: principles of transcriptional control by developmental cell signaling. Genes Dev. 16:1167-81
19. Gerhart J. 1999. 1998 Warkany lecture: signaling pathways in development. Teratology 60:226-39
20. Dexter JS. 1914. The analysis of a case of continuous variation in Drosophila by a study of its linkage relations. Am. Nat. 48:712-58
21. Artavanis-Tsakonas S, Muskavitch MA, Yedvobnick B. 1983. Molecular cloning of Notch, a locus affecting neurogenesis in Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 80:1977-81
22. Vassin H, Bremer KA, Knust E, Campos-Ortega JA. 1987. The neurogenic gene Delta of Drosophila melanogaster is expressed in neurogenic territories and encodes a putative transmembrane protein with EGF-like repeats. EMBO J. 6:3431-40
23. Fleming RJ, Scottgale TN, Diederich RJ, Artavanis-Tsakonas S. 1990. The gene Serrate encodes a putative EGF-like transmembrane protein essential for proper ectodermal development in Drosophila melanogaster. Genes Dev. 4:2188-201
24. Kovall RA, Blacklow SC. 2010. Mechanistic insights into Notch receptor signaling from structural and biochemical studies. Curr. Top. Dev. Biol. 92:31-71
25. Ladi E, Nichols JT, Ge W, Miyamoto A, Yao C, et al. 2005. The divergent DSL ligand Dll3 does not activate Notch signaling but cell autonomously attenuates signaling induced by other DSL ligands. J. Cell Biol. 170:983-92
26. Stanley P, Okajima T. 2010. Roles of glycosylation in Notch signaling. Curr. Top. Dev. Biol. 92:131-64
27. Okajima T, Irvine KD. 2002. Regulation of notch signaling by O-linked fucose. Cell 111:893-904
28. Moloney DJ, Panin VM, Johnston SH, Chen J, Shao L, et al. 2000. Fringe is a glycosyltransferase that modifies Notch. Nature 406:369-75
29. Logeat F, Bessia C, Brou C, LeBail O, Jarriault S, et al. 1998. The Notch1 receptor is cleaved constitutively by a furin-like convertase. Proc. Natl. Acad. Sci. USA 95:8108-12
30. van Tetering G, van Diest P, Verlaan I, van der Wall E, Kopan R, Vooijs M. 2009. Metalloprotease ADAM10 is required for Notch1 site 2 cleavage. J. Biol. Chem. 284:31018-27
31. De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, et al. 1999. A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain. Nature 398:518-22
32. Fryer CJ, White JB, Jones KA. 2004. Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. Mol. Cell 16:509-20
33. Musse AA, Meloty-Kapella L, Weinmaster G. 2012. Notch ligand endocytosis: mechanistic basis of signaling activity. Semin. Cell Dev. Biol. 23:429-36
34. Rajan A, Tien AC, Haueter CM, Schulze KL, Bellen HJ. 2009. The Arp2/3 complex and WASp are required for apical trafficking of Delta into microvilli during cell fate specification of sensory organ precursors. Nat. Cell Biol. 11:815-24
35. Nichols JT, Miyamoto A, Olsen SL, D'Souza B, Yao C, Weinmaster G. 2007. DSL ligand endocytosis physically dissociates Notch1 heterodimers before activating proteolysis can occur. J. Cell Biol. 176:445-58
36. Song R, Koo BK, Yoon KJ, Yoon MJ, Yoo KW, et al. 2006. Neuralized-2 regulates a Notch ligand in cooperation with Mind bomb-1. J. Biol. Chem. 281:36391-400
37. Yamamoto S, Charng WL, Bellen HJ. 2010. Endocytosis and intracellular trafficking of Notch and its ligands. Curr. Top. Dev. Biol. 92:165-200
38. Lai EC. 2002. Protein degradation: four E3s for the notch pathway. Curr. Biol. 12:R74-78
39. Sun Y, Klauzinska M, Lake RJ, Lee JM, Santopietro S, et al. 2011. Trp53 regulates Notch 4 signaling through Mdm2. J. Cell Sci. 124:1067-76
40. Qiu L, Joazeiro C, Fang N, Wang HY, Elly C, et al. 2000. Recognition and ubiquitination of Notch by Itch, a hect-type E3 ubiquitin ligase. J. Biol. Chem. 275:35734-37
41. Pece S, Confalonieri S, R Romano P, Di Fiore PP. 2011. NUMB-ing down cancer by more than just a NOTCH. Bioch. Biophys. Acta 1815:26-43
42. McGill MA, Dho SE, Weinmaster G, McGlade CJ. 2009. Numb regulates post-endocytic trafficking and degradation of Notch1. J. Biol. Chem. 284:26427-38
43. Couturier L, Vodovar N, Schweisguth F. 2012. Endocytosis by Numb breaks Notch symmetry at cytokinesis. Nat. Cell Biol. 14:131-9
44. del Alamo D, Rouault H, Schweisguth F. 2011. Mechanism and significance of cis-inhibition in Notch signalling. Curr. Biol. 21:R40-47
45. Zolkiewska A. 2008. ADAM proteases: ligand processing and modulation of the Notch pathway. Cell. Mol. Life Sci. 65:2056-68
46. Sun D, Li H, Zolkiewska A. 2008. The role of Delta-like 1 shedding in muscle cell self-renewal and differentiation. J. Cell Sci. 121:3815-23
47. Kolev V, Kacer D, Trifonova R, Small D, Duarte M, et al. 2005. The intracellular domain of Notch ligand Delta1 induces cell growth arrest. FEBS Lett. 579:5798-802
48. LaVoie MJ, Selkoe DJ. 2003. The Notch ligands, Jagged and Delta, are sequentially processed by α-secretase and presenilin/γ-secretase and release signaling fragments. J. Biol. Chem. 278:34427-37
49. Estrach S, Legg J, Watt FM. 2007. Syntenin mediates Delta1-induced cohesiveness of epidermal stem cells in culture. J. Cell Sci. 120:2944-52
50. D'Souza B, Meloty-Kapella L, Weinmaster G. 2010. Canonical and non-canonical Notch ligands. Curr. Top. Dev. Biol. 92:73-129
51. Hu QD, Ang BT, Karsak M, Hu WP, Cui XY, et al. 2003. F3/contactin acts as a functional ligand for Notch during oligodendrocyte maturation. Cell 115:163-75
52. Mukherjee A, Veraksa A, Bauer A, Rosse C, Camonis J, Artavanis-Tsakonas S. 2005. Regulation of Notch signalling by non-visual β-arrestin. Nat. Cell Biol. 7:1191-201
53. Schroder N, Gossler A. 2002. Expression of Notch pathway components in fetal and adult mouse small intestine. Gene Expr. Patterns 2:247-50
54. Sander GR, Powell BC. 2004. Expression of Notch receptors and ligands in the adult gut. J. Histochem. Cytochem. 52:509-16
55. Fre S, Hannezo E, Sale S, Huyghe M, Lafkas D, et al. 2011. Notch lineages and activity in intestinal stem cells determined by a new set of knock-in mice. PLoS ONE 6:e25785
56. Vooijs M, Ong CT, Hadland B, Huppert S, Liu Z, et al. 2007. Mapping the consequence of Notch1 proteolysis in vivo with NIP-CRE. Development 134:535-44
57. VanDussen KL, Carulli AJ, Keeley TM, Patel SR, Puthoff BJ, et al. 2012. Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells. Development 139:488-97
58. Sato T, van Es JH, Snippert HJ, Stange DE, Vries RG, et al. 2011. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 469:415-18
59. + stem cells in mice. Gastroenterology 142:1195-205. e6
60. Searfoss GH, Jordan WH, Calligaro DO, Galbreath EJ, Schirtzinger LM, et al. 2003. Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional γ-secretase inhibitor. J. Biol. Chem. 278:46107-16
61. Milano J, McKay J, Dagenais C, Foster-Brown L, Pognan F, et al. 2004. Modulation of notch processing by γ-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation. Toxicol. Sci. 82:341-58
62. Wong GT, Manfra D, Poulet FM, Zhang Q, Josien H, et al. 2004. Chronic treatment with the γ-secretase inhibitor LY-411, 575 inhibits β-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation. J. Biol. Chem. 279:12876-82
63. van Es JH, van Gijn ME, Riccio O, van den Born M, Vooijs M, et al. 2005. Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 435:959-63
64. Kip2. EMBO Rep. 9:377-83
65. Fre S, Huyghe M, Mourikis P, Robine S, Louvard D, Artavanis-Tsakonas S. 2005. Notch signals control the fate of immature progenitor cells in the intestine. Nature 435:964-68
66. Stanger BZ, Datar R, Murtaugh LC, Melton DA. 2005. Direct regulation of intestinal fate by Notch. Proc. Natl. Acad. Sci. USA 102:12443-48
67. van Es JH, de Geest N, van de Born M, Clevers H, Hassan BA. 2010. Intestinal stem cells lacking the Math1 tumour suppressor are refractory to Notch inhibitors. Nat. Commun. 1:18
68. Pellegrinet L, Rodilla V, Liu Z, Chen S, Koch U, et al. 2011. Dll1-and dll4-mediated notch signaling are required for homeostasis of intestinal stem cells. Gastroenterology 140:1230-40. e1-7
69. Stamataki D, Holder M, Hodgetts C, Jeffery R, Nye E, et al. 2011. Delta1 expression, cell cycle exit, and commitment to a specific secretory fate coincide within a few hours in the mouse intestinal stem cell system. PLoS ONE 6:e24484
70. Koo BK, Lim HS, Chang HJ, Yoon MJ, Choi Y, et al. 2009. Notch signaling promotes the generation of EphrinB1-positive intestinal epithelial cells. Gastroenterology 137:145-55, 55. e1-3
71. Waterhouse CC, Johnson S, Phillipson M, Zbytnuik L, Petri B, et al. 2010. Secretory cell hyperplasia and defects in Notch activity in a mouse model of leukocyte adhesion deficiency type II. Gastroenterology 138:1079-90. e1-5
72. Guilmeau S, Flandez M, Bancroft L, Sellers RS, Tear B, et al. 2008. Intestinal deletion of Pofut1 in the mouse inactivates notch signaling and causes enterocolitis. Gastroenterology 135:849-60, 60. e1-6
73. Yang Y, Zhu R, Bai J, Zhang X, Tian Y, et al. 2011. Numb modulates intestinal epithelial cells toward goblet cell phenotype by inhibiting the Notch signaling pathway. Exp. Cell Res. 317:1640-48
74. Sureban SM, May R, George RJ, Dieckgraefe BK, McLeod HL, et al. 2008. Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo. Gastroenterology 134:1448-58
75. Rezza A, Skah S, Roche C, Nadjar J, Samarut J, Plateroti M. 2010. The overexpression of the putative gut stem cell marker Musashi-1 induces tumorigenesis through Wnt and Notch activation. J. Cell Sci. 123:3256-65
76. Jensen J, Pedersen EE, Galante P, Hald J, Heller RS, et al. 2000. Control of endodermal endocrine development by Hes-1. Nat. Genet. 24:36-44
77. Suzuki K, Fukui H, Kayahara T, Sawada M, Seno H, et al. 2005. Hes1-deficient mice show precocious differentiation of Paneth cells in the small intestine. Biochem. Biophys. Res. Commun. 328:348-52
78. Ueo T, Imayoshi I, Kobayashi T, Ohtsuka T, Seno H, et al. 2012. The role of Hes genes in intestinal development, homeostasis and tumor formation. Development 139:1071-82
79. Zheng X, Tsuchiya K, Okamoto R, Iwasaki M, Kano Y, et al. 2011. Suppression of hath1 gene expression directly regulated by hes1 via notch signaling is associated with goblet cell depletion in ulcerative colitis. Inflamm. Bowel Dis. 17:2251-60
80. Yang Q, Bermingham NA, Finegold MJ, Zoghbi HY. 2001. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science 294:2155-58
81. Shroyer NF, Helmrath MA, Wang VY, Antalffy B, Henning SJ, Zoghbi HY. 2007. Intestine-specific ablation of mouse atonal homolog 1 (Math1) reveals a role in cellular homeostasis. Gastroenterology 132:2478-88
82. Kim TH, Shivdasani RA. 2011. Genetic evidence that intestinal Notch functions vary regionally and operate through a common mechanism of Math1 repression. J. Biol. Chem. 286:11427-33
83. Kazanjian A, Noah T, Brown D, Burkart J, Shroyer NF. 2010. Atonal homolog 1 is required for growth and differentiation effects of notch/γ-secretase inhibitors on normal and cancerous intestinal epithelial cells. Gastroenterology 139:918-28, 28. e1-6
84. VanDussen KL, Samuelson LC. 2010. Mouse atonal homolog 1 directs intestinal progenitors to secretory cell rather than absorptive cell fate. Dev. Biol. 346:215-23
85. Lee CS, Perreault N, Brestelli JE, Kaestner KH. 2002. Neurogenin 3 is essential for the proper specification of gastric enteroendocrine cells and the maintenance of gastric epithelial cell identity. Genes Dev. 16:1488-97
86. Jenny M, Uhl C, Roche C, Duluc I, Guillermin V, et al. 2002. Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium. EMBO J. 21:6338-47
87. Lopez-Diaz L, Jain RN, Keeley TM, VanDussen KL, Brunkan CS, et al. 2007. Intestinal Neurogenin 3 directs differentiation of a bipotential secretory progenitor to endocrine cell rather than goblet cell fate. Dev. Biol. 309:298-305
88. Shroyer NF, Wallis D, Venken KJ, Bellen HJ, Zoghbi HY. 2005. Gfi1 functions downstream of Math1 to control intestinal secretory cell subtype allocation and differentiation. Genes Dev. 19:2412-17
89. Bjerknes M, Cheng H. 2010. Cell lineage metastability in Gfi1-deficient mouse intestinal epithelium. Dev. Biol. 345:49-63
90. May CL, Kaestner KH. 2010. Gut endocrine cell development. Mol. Cell. Endocrinol. 323:70-75
91. Noah TK, Kazanjian A, Whitsett J, Shroyer NF. 2010. SAM pointed domain ETS factor (SPDEF) regulates terminal differentiation and maturation of intestinal goblet cells. Exp. Cell Res. 316:452-65
92. Katz JP, Perreault N, Goldstein BG, Lee CS, Labosky PA, et al. 2002. The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development 129:2619-28
93. Real PJ, Tosello V, Palomero T, Castillo M, Hernando E, et al. 2009. γ-Secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia. Nat. Med. 15:50-58
94. Zecchini V, Domaschenz R, Winton D, Jones P. 2005. Notch signaling regulates the differentiation of post-mitotic intestinal epithelial cells. Genes Dev. 19:1686-91
95. Bjerknes M, Cheng H. 2006. Neurogenin 3 and the enteroendocrine cell lineage in the adult mouse small intestinal epithelium. Dev. Biol. 300:722-35
96. Bjerknes M, Cheng H. 1999. Clonal analysis of mouse intestinal epithelial progenitors. Gastroenterology 116:7-14
97. Li HJ, Kapoor A, Giel-Moloney M, Rindi G, Leiter AB. 2012. Notch signaling differentially regulates the cell fate of early endocrine precursor cells and their maturing descendants in the mouse pancreas and intestine. Dev. Biol. 371(2):156-69
98. Gerbe F, van Es JH, Makrini L, Brulin B, Mellitzer G, et al. 2011. Distinct ATOH1 and Neurog3 requirements define tuft cells as a new secretory cell type in the intestinal epithelium. J. Cell Biol. 192:767-80
99. Bjerknes M, Khandanpour C, Moroy T, Fujiyama T, Hoshino M, et al. 2012. Origin of the brush cell lineage in the mouse intestinal epithelium. Dev. Biol. 362:194-218
100. Kim TH, Kim BM, Mao J, Rowan S, Shivdasani RA. 2011. Endodermal Hedgehog signals modulate Notch pathway activity in the developing digestive tract mesenchyme. Development 138:3225-33
101. Okamura Y, Saga Y. 2008. Notch signaling is required for the maintenance of enteric neural crest progenitors. Development 135:3555-65
102. Ngan ES, Garcia-Barcelo MM, Yip BH, Poon HC, Lau ST, et al. 2011. Hedgehog/Notch-induced premature gliogenesis represents a new disease mechanism for Hirschsprung disease in mice and humans. J. Clin. Investig. 121:3467-78
103. Crosnier C, Vargesson N, Gschmeissner S, Ariza-McNaughton L, Morrison A, Lewis J. 2005. Delta-Notch signalling controls commitment to a secretory fate in the zebrafish intestine. Development 132:1093-104
104. Ohlstein B, Spradling A. 2007. Multipotent Drosophila intestinal stem cells specify daughter cell fates by differential notch signaling. Science 315:988-92
105. Fre S, Bardin A, Robine S, Louvard D. 2011. Notch signaling in intestinal homeostasis across species: the cases of Drosophila, zebrafish and the mouse. Exp. Cell Res. 317:2740-47
106. Perdigoto CN, Schweisguth F, Bardin AJ. 2011. Distinct levels of Notch activity for commitment and terminal differentiation of stem cells in the adult fly intestine. Development 138:4585-95
107. Yang J, Chan CY, Jiang B, Yu X, Zhu GZ, et al. 2009. hnRNP I inhibits Notch signaling and regulates intestinal epithelial homeostasis in the zebrafish. PLoS Genet. 5:e1000363
108. Demarest RM, Ratti F, Capobianco AJ. 2008. It's T-ALL about Notch. Oncogene 27:5082-91
109. Zagouras P, Stifani S, Blaumueller CM, Carcangiu ML, Artavanis-Tsakonas S. 1995. Alterations in Notch signaling in neoplastic lesions of the human cervix. Proc. Natl. Acad. Sci. USA 92:6414-18
110. Reedijk M, Odorcic S, Zhang H, Chetty R, Tennert C, et al. 2008. Activation of Notch signaling in human colon adenocarcinoma. Int. J. Oncol. 33:1223-29
111. Guilmeau S. 2012. Notch signaling and intestinal cancer. Adv. Exp. Med. Biol. 727:272-88
112. Kazanjian A, Shroyer NF. 2011. NOTCH signaling and ATOH1 in colorectal cancers. Curr. Colorectal Cancer Rep. 7:121-27
113. Chu D, Li Y, Wang W, Zhao Q, Li J, et al. 2010. High level of Notch1 protein is associated with poor overall survival in colorectal cancer. Ann. Surg. Oncol. 17:1337-42
114. + tumor-initiating cells exhibiting gain in NOTCH1 gene copy number have enhanced regrowth sensitivity to a γ-secretase inhibitor and irinotecan in colorectal cancer. Mol. Oncol. 6:370-81
115. Fre S, Pallavi SK, Huyghe M, Lae M, Janssen KP, et al. 2009. Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine. Proc. Natl. Acad. Sci. USA 106:6309-14
116. Peignon G, Durand A, Cacheux W, Ayrault O, Terris B, et al. 2011. Complex interplay between β-catenin signalling and Notch effectors in intestinal tumorigenesis. Gut 60:166-76
117. Rodilla V, Villanueva A, Obrador-Hevia A, Robert-Moreno A, Fernandez-Majada V, et al. 2009. Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer. Proc. Natl. Acad. Sci. USA 106:6315-20
118. Guilmeau S, Flandez M, Mariadason JM, Augenlicht LH. 2010. Heterogeneity of Jagged1 expression in human and mouse intestinal tumors: implications for targeting Notch signaling. Oncogene 29:992-1002
119. Rajagopalan H, Jallepalli PV, Rago C, Velculescu VE, Kinzler KW, et al. 2004. Inactivation of hCDC4 can cause chromosomal instability. Nature 428:77-81
120. Babaei-Jadidi R, Li N, Saadeddin A, Spencer-Dene B, Jandke A, et al. 2011. FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation. J. Exp. Med. 208:295-312
121. Sancho R, Jandke A, Davis H, Diefenbacher ME, Tomlinson I, Behrens A. 2010. F-box and WD repeat domain-containing 7 regulates intestinal cell lineage commitment and is a haploinsufficient tumor suppressor. Gastroenterology 139:929-41
122. Sonoshita M, Aoki M, Fuwa H, Aoki K, Hosogi H, et al. 2011. Suppression of colon cancer metastasis by Aes through inhibition of Notch signaling. Cancer Cell 19:125-37
123. Garcia A, Kandel JJ. 2012. Notch: a key regulator of tumor angiogenesis and metastasis. Histol. Histopathol. 27:151-56
124. Noguera-Troise I, Daly C, Papadopoulos NJ, Coetzee S, Boland P, et al. 2006. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 444:1032-37
125. Ridgway J, Zhang G, Wu Y, Stawicki S, Liang WC, et al. 2006. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 444:1083-87
126. Yan M, Callahan CA, Beyer JC, Allamneni KP, Zhang G, et al. 2010. Chronic DLL4 blockade induces vascular neoplasms. Nature 463:E6-7
127. Akiyoshi T, Nakamura M, Yanai K, Nagai S, Wada J, et al. 2008. γ-Secretase inhibitors enhance taxane-induced mitotic arrest and apoptosis in colon cancer cells. Gastroenterology 134:131-44
128. Aleksic T, Feller SM. 2008. Gamma-secretase inhibition combined with platinum compounds enhances cell death in a large subset of colorectal cancer cells. Cell Commun. Signal. 6:8
129. Liu SK, Bham SA, Fokas E, Beech J, Im J, et al. 2011. Delta-like ligand 4-notch blockade and tumor radiation response. J. Natl. Cancer Inst. 103:1778-98
130. Hoey T, Yen WC, Axelrod F, Basi J, Donigian L, et al. 2009. DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency. Cell Stem Cell 5:168-77
131. Fischer M, Yen WC, Kapoun AM, Wang M, O'Young G, et al. 2011. Anti-DLL4 inhibits growth and reduces tumor-initiating cell frequency in colorectal tumors with oncogenic KRAS mutations. Cancer Res. 71: 1520-25
132. Strosberg JR, Yeatman T, Weber J, Coppola D, Schell MJ, et al. 2012. A phase II study of RO4929097 in metastatic colorectal cancer. Eur. J. Cancer 48:997-1003
133. Park ET, Oh HK, Gum JR Jr, Crawley SC, Kakar S, et al. 2006. HATH1 expression in mucinous cancers of the colorectum and related lesions. Clin. Cancer Res. 12:5403-10
134. Leow CC, Romero MS, Ross S, Polakis P, Gao WQ. 2004. Hath1, down-regulated in colon adenocarcinomas, inhibits proliferation and tumorigenesis of colon cancer cells. Cancer Res. 64:6050-57
135. Bossuyt W, Kazanjian A, De Geest N, Van Kelst S, De Hertogh G, et al. 2009. Atonal homolog 1 is a tumor suppressor gene. PLoS Biol. 7:e39
136. Ohashi S, Natsuizaka M, Yashiro-Ohtani Y, Kalman RA, Nakagawa M, et al. 2010. NOTCH1 and NOTCH3 coordinate esophageal squamous differentiation through a CSL-dependent transcriptional network. Gastroenterology 139:2113-23
137. Kim TH, Shivdasani RA. 2011. Notch signaling in stomach epithelial stem cell homeostasis. J. Exp. Med. 208:677-88
138. Tamagawa Y, Ishimura N, Uno G, Yuki T, Kazumori H, et al. 2012. Notch signaling pathway and Cdx2 expression in the development of Barrett's esophagus. Lab. Investig. 92:896-909
139. Piazzi G, Fini L, Selgrad M, Garcia M, Daoud Y, et al. 2011. Epigenetic regulation of Delta-Like1 controls Notch1 activation in gastric cancer. Oncotarget 2:1291-301
140. Kong J, Crissey MA, Sepulveda AR, Lynch JP. 2012. Math1/Atoh1 contributes to intestinalization of esophageal keratinocytes by inducing the expression of Muc2 and Keratin-20. Dig. Dis. Sci. 57:845-57
141. Mutoh H, Sakamoto H, Hayakawa H, Arao Y, Satoh K, et al. 2006. The intestine-specific homeobox gene Cdx2 induces expression of the basic helix-loop-helix transcription factor Math1. Differentiation 74:313-21
142. Menke V, van Es JH, de Lau W, van den Born M, Kuipers EJ, et al. 2010. Conversion of metaplastic Barrett's epithelium into post-mitotic goblet cells by γ-secretase inhibition. Dis. Models Mech. 3:104-10
143. Bernstein CN, Blanchard JF, Kliewer E, Wajda A. 2001. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 91:854-62
144. Okamoto R, Tsuchiya K, Nemoto Y, Akiyama J, Nakamura T, et al. 2009. Requirement of Notch activation during regeneration of the intestinal epithelia. Am. J. Physiol. Gastrointest. Liver Physiol. 296:G23-35
145. Gersemann M, Becker S, Kubler I, Koslowski M, Wang G, et al. 2009. Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis. Differentiation 77:84-94
146. Wehkamp J, Salzman NH, Porter E, Nuding S, Weichenthal M, et al. 2005. Reduced Paneth cell α-defensins in ileal Crohn's disease. Proc. Natl. Acad. Sci. USA 102:18129-34
147. + T cells, in mice and humans. Gastroenterology 140:550-59
148. Capuano M, Iaffaldano L, Tinto N, Montanaro D, Capobianco V, et al. 2011. MicroRNA-449a overexpression, reduced NOTCH1 signals and scarce goblet cells characterize the small intestine of celiac patients. PLoS ONE 6:e29094